Revance Therapeutics Inc banner

Revance Therapeutics Inc
NASDAQ:RVNC

Watchlist Manager
Revance Therapeutics Inc Logo
Revance Therapeutics Inc
NASDAQ:RVNC
Watchlist
Price: 3.65 USD Market Closed
Market Cap: $381m

Intrinsic Value

The intrinsic value of one RVNC stock under the Base Case scenario is 4.18 USD. Compared to the current market price of 3.65 USD, Revance Therapeutics Inc is Undervalued by 13%.

RVNC Intrinsic Value
4.18 USD
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Revance Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about RVNC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RVNC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Revance Therapeutics Inc.

Explain Valuation
Compare RVNC to

Wall St
Price Targets

Dividends

Revance Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

RVNC Insider Trading
Buy and sell transactions by insiders

RVNC News

What is the Intrinsic Value of one RVNC stock?

The intrinsic value of one RVNC stock under the Base Case scenario is 4.18 USD.

Is RVNC stock undervalued or overvalued?

Compared to the current market price of 3.65 USD, Revance Therapeutics Inc is Undervalued by 13%.

Back to Top